A new study, “The 340B Drug Discount Program Exceeds $100B in 2022,” shows the program is misused.
Taxpayers Do Not Get Everything They Want But They Get What They Need
The Fiscal Responsibility Act is what taxpayers need and will lead to more of what they want to reduce wasteful spending.
Harm Reduction Is Vital on World Vape Day
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.
Recognizing Women’s Medical Innovations on World IP Day
Intellectual property rights must be protected to encourage future research and development of life saving cures.
West Virginia Should Continue to Repeal Burdensome CON Laws
SB 613 partially repeals West Virginia’s harmful Certificate of Need laws.
Attacking PBMs Won’t Result in Lower Drug Costs
SB 1550 will negatively impact Florida’s private sector healthcare market and ultimately harm patients.
New York Takes the Wrong Approach to Tobacco
New York’s proposed tax and flavor ban would negatively impact tobacco harm reduction efforts and public health.
The Cantwell-Grassley PBM Bill is a Wolf in Sheep’s Clothing
A Bill introduced in the Senate takes aim at PBMS and private sector healthcare.
Patients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
House Committees Hold Oversight Hearings on COVID-19 Relief Fraud
Long overdue oversight hearings were finally held in the House of Representatives.